BriaCell Therapeutics Management
Management criteria checks 2/4
BriaCell Therapeutics' CEO is Bill Williams, appointed in Oct 2016, has a tenure of 7.5 years. total yearly compensation is $1.22M, comprised of 60.6% salary and 39.4% bonuses, including company stock and options. directly owns 0.94% of the company’s shares, worth €299.30K. The average tenure of the management team and the board of directors is 7.5 years and 5.1 years respectively.
Key information
Bill Williams
Chief executive officer
US$1.2m
Total compensation
| CEO salary percentage | 60.6% |
| CEO tenure | 7.5yrs |
| CEO ownership | 0.9% |
| Management average tenure | 7.5yrs |
| Board average tenure | 5.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jan 31 2024 | n/a | n/a | -US$13m |
| Oct 31 2023 | n/a | n/a | -US$13m |
| Jul 31 2023 | US$1m | US$737k | -US$20m |
| Apr 30 2023 | n/a | n/a | -US$18m |
| Jan 31 2023 | n/a | n/a | -US$23m |
| Oct 31 2022 | n/a | n/a | -US$412k |
| Jul 31 2022 | US$811k | US$561k | -US$27m |
| Apr 30 2022 | n/a | n/a | -US$42m |
| Jan 31 2022 | n/a | n/a | -US$30m |
| Oct 31 2021 | n/a | n/a | -US$41m |
| Jul 31 2021 | US$830k | US$218k | -US$14m |
| Apr 30 2021 | n/a | n/a | US$2m |
| Jan 31 2021 | n/a | n/a | -US$2m |
| Oct 31 2020 | n/a | n/a | -US$3m |
| Jul 31 2020 | US$231k | US$231k | -US$4m |
| Apr 30 2020 | n/a | n/a | -US$4m |
| Jan 31 2020 | n/a | n/a | -US$5m |
| Oct 31 2019 | n/a | n/a | -US$5m |
| Aug 01 2019 | n/a | n/a | -US$5m |
| Apr 30 2019 | n/a | n/a | -US$5m |
| Jan 31 2019 | n/a | n/a | -US$5m |
| Oct 31 2018 | n/a | n/a | -US$4m |
| Jul 31 2018 | US$228k | US$175k | -US$4m |
| Apr 30 2018 | n/a | n/a | -US$3m |
| Jan 31 2018 | n/a | n/a | -US$3m |
| Oct 31 2017 | n/a | n/a | -US$3m |
| Jul 31 2017 | US$208k | US$140k | -US$3m |
Compensation vs Market: Bill's total compensation ($USD1.22M) is above average for companies of similar size in the German market ($USD401.52K).
Compensation vs Earnings: Bill's compensation has increased whilst the company is unprofitable.
CEO
Bill Williams (68 yo)
7.5yrs
Tenure
US$1,215,514
Compensation
Dr. William V. Williams, M.D., FRCP, also known as Bill, has been the Chief Executive Officer and President of BriaCell Therapeutics Corp. since October 2016 and serves as its Director Since November 11, 2...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 7.5yrs | US$1.22m | 0.94% $ 299.3k | |
| CFO & Corporate Secretary | 8.2yrs | US$391.44k | 0.018% $ 5.6k | |
| Chief Scientific Officer | 1.9yrs | US$368.44k | 0% $ 0 | |
| Chief Medical Officer | 2.2yrs | US$948.90k | 0% $ 0 | |
| Founder | 8.8yrs | US$241.14k | no data |
7.5yrs
Average Tenure
61yo
Average Age
Experienced Management: 8BT's management team is seasoned and experienced (7.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 7.4yrs | US$1.22m | 0.94% $ 299.3k | |
| Founder | 3.3yrs | US$241.14k | no data | |
| Member of Scientific Advisory Board | 6.9yrs | no data | no data | |
| Independent Director | 2.6yrs | US$163.44k | 10.39% $ 3.3m | |
| Independent Director | 3.4yrs | US$170.94k | 0.0036% $ 1.2k | |
| Independent Director | 5.1yrs | US$95.44k | 0% $ 0 | |
| Lead Independent Director | 5.1yrs | US$187.23k | 0.060% $ 19.0k | |
| Member of Scientific Advisory Board | 6.9yrs | no data | no data | |
| Member of Scientific Advisory Board | 6.9yrs | no data | no data | |
| Member of Scientific Advisory Board | 6.9yrs | no data | no data | |
| Independent Chairman of the Board | 5.2yrs | US$677.08k | 0.75% $ 239.7k | |
| Member of Scientific Advisory Board | 4.6yrs | no data | no data |
5.1yrs
Average Tenure
67yo
Average Age
Experienced Board: 8BT's board of directors are considered experienced (5.1 years average tenure).